ENLIGHT Network

The European Network for Light Ion Hadron Therapy (ENLIGHT) is a multidisciplinary platform that unites experts in radiotherapy, oncology, medical physics, engineering, and accelerator science to advance hadron therapy for cancer treatment. Established in 2002 with the support of the European Commission, ENLIGHT fosters collaboration across Europe to enhance the effectiveness, accessibility, and innovation of hadron therapy, particularly using proton and light-ion beams. Hadron therapy, a cutting-edge cancer treatment, offers unparalleled precision in targeting tumors while minimizing damage to surrounding healthy tissues. This makes it particularly beneficial for treating complex, radio-resistant, or pediatric cancers. ENLIGHT provides a unique framework where researchers, clinicians, and industry leaders work together to optimize treatment protocols, integrate emerging technologies, and drive the future of hadron therapy. With over 20 years of impact, ENLIGHT serves as a knowledge hub, promoting education, research, and strategic partnerships across Europe. It connects leading hadron therapy centers, academic institutions, and industrial partners, ensuring continuous advancements in treatment planning, facility development, and patient outcomes. The network also plays a crucial role in training the next generation of professionals through dedicated workshops, collaborative projects, and mentorship opportunities. ENLIGHT is instrumental in bridging the gap between physics, medicine, and technology, helping to shape the future of precision cancer therapy. By fostering a collaborative environment, ENLIGHT supports the evolution of hadron therapy, contributing to a more effective, personalized, and accessible approach to cancer treatment across Europe and beyond. 🚀 Join us in advancing the future of hadron therapy! 🔗 Learn more: https://enlight.web.cern.ch/